Skip to main content

Cancer Moonshot℠ - Funding by Research Category

To ensure the Cancer Moonshot goals and approaches were grounded in the best science, NCI convened a Blue Ribbon Panel (BRP) of scientific experts as a working group to the National Cancer Advisory board. In September of 2016, the BRP presented a final report outlining 10 research recommendations that represent areas that are well-positioned to accelerate progress in cancer prevention, diagnosis, treatment and care.

Download Table Data

The following research categories align with these 10 recommendations:

Cancer Moonshot by Category, FY 2018
(Whole Dollars)
Research Category Amount
Network for Direct Patient Engagement     $864,531
Cancer Immunotherapy Translational Science Network     $67,643,470
Therapeutic Target Identification to Overcome Drug Resistance    

$4,005,166

A National Cancer Data Ecosystem for Sharing and Analysis    

$9,557,020

Fusion Oncoproteins in Childhood Cancers    

$37,358,770

Minimize Cancer Treatment’s Debilitating Side Effects

$32,162,876

Prevention and early detection: Implementation of Evidence-Based Approaches

$32,547,322

Retrospective Analysis of Biospecimens form Patients Treated with Standard of Care

$8,370,414

Generation of Human Tumor Atlases

$74,246,242

Development of New Enabling Cancer Technologies

$38,356,361

Other Cancer Moonshot priority activities (e.g., Partnership for Accelerating Cancer Therapies)

-

Total $305,112,172
 Includes FY 2017 Cures-Moonshot Carryover obligations.

 

  • Posted: